Status:

COMPLETED

Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA During the Radioembolisation Pretreatment Procedure

Lead Sponsor:

UMC Utrecht

Conditions:

Liver Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To establish the safety and feasibility of interventional x-ray and scintigraphy imaging during the pre-treatment procedure of hepatic radioembolization

Eligibility Criteria

Inclusion

  • Participants must have given written informed consent and comply with the requirements of the study protocol.
  • Must be aged 18 years or over.
  • Must be selected to undergo a 99mTc-MAA procedure as part of their radioembolisation treatment.
  • Sufficiently fit to undergo an additional examination time of 30-90 minutes.
  • Have a CT acquired less than 6 weeks before the pre-treatment radioembolisation procedure.

Exclusion

  • Patients expected to require more than two injection positions for radioembolisation treatment.
  • Pregnancy or nursing.
  • Patients suffering from psychic disorders that make a comprehensive judgement impossible, such as psychosis, hallucinations and/or depression.
  • Patients who are declared incompetent.
  • Previous enrollment in the present study
  • Claustrophobia
  • The last dose of prior chemotherapy has been received less than weeks prior to the planned 99mTc-MAA pre-treatment procedure.
  • Radiation therapy within the last 4 weeks before the planned 99mTc-MAA pre-treatment procedure
  • Major surgery within the last 4 weeks prior to the planned 99mTc-MAA pre-treatment procedure
  • Any unresolved toxicity greater than Common Terminology Criteria for Adverse Events (CTCAE version 5) grade 2 from previous anti-cancer treatment
  • Body weight over 250 kg (because of maximum table load)
  • Patient length over 1.90 m (to fit IXSI geometry)
  • Patient bust line over 135 cm (to fit IXSI geometry)

Key Trial Info

Start Date :

May 25 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 16 2023

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT06013774

Start Date

May 25 2021

End Date

January 16 2023

Last Update

August 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UMC Utrecht

Utrecht, Netherlands